Anthony Hunt - 21 Nov 2024 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Role
Director
Signature
/s/ Marc Baumgartner (Attorney in Fact)
Issuer symbol
RGEN
Transactions as of
21 Nov 2024
Net transactions value
-$2,565,227
Form type
4
Filing time
22 Nov 2024, 16:52:20 UTC
Previous filing
12 Sep 2024
Next filing
05 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGEN Common Stock Options Exercise $821,212 +24,246 +17% $33.87 164,086 21 Nov 2024 Direct
transaction RGEN Common Stock Sale $3,386,439 -24,246 -15% $139.67 139,840 21 Nov 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGEN Stock Option (Right to Buy) Options Exercise $0 +24,246 $0.000000 0 21 Nov 2024 Common Stock 24,246 $33.87 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction undertaken consistent with a previously arranged transaction under the reporting person's Rule 10(b)5-1 trading plan, which expired on November 15, 2024.
F2 $139.67 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.25 to $140.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 This option is fully vested and exercisable.

Remarks:

Exhibit 24.1: Power of Attorney